Oslo University Hospital
Oslo, 0027, Norway
NCT Number: NCT01206868
A single centre open randomised parallel-group study to evaluate whether prophylactic fenestration of the peritoneum at the time of renal transplantation prevents lymphocele formation.
Adult (>18 years old) recipients of renal transplants from deceased donors were eligible for inclusion. From March 2007 to May 2009 130 patients were included. The patients were randomized either to peroperative peritoneal fenestration, or to serve as controls. Block-randomization was conducted in groups of 10, drawn from envelopes containing five notes from each group. Patients who previously had undergone extensive abdominal surgery, or were included in other studies were excluded.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oslo, 0027, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fenestration of the peritoneum according to the length of the transplanted kidney
Standard kidney transplantation
Time frame: 1 - 3 years
Symptomatic lymphoceles treated by surgical intervetion or ultrasound guided drainage
Time frame: 1 -10 weeks
Oslo University Hospital
Other
Prospective Open Randomized Study to Evaluate the Efficiency of Prophylactic Fenestration of the Peritoneum in Kidney Transplantation in Preventing the Occurrence of Postoperative Lymphoceles
Acronym: PROFFEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02894021
Cysts, Hemic and Lymphatic Diseases
Amiens, France
View Trial DetailsNCT01742975
Breast Cancer, Breast Diseases
Grenoble, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT06284135
Cysts, Genital Diseases
Hamburg, Germany
View Trial DetailsNCT04853095
Cysts, Genital Diseases
Olomouc, Czechia
View Trial Details